Monday’s insider activity: Major buys at Cardinal, Apollomics

Investing.com reports U.S. insider trades disclosed Monday. Apollomics (APLM) saw CEO Hung-Wen Chen buy about $7.55M and CFO Peter Lin buy $400k. Cardinal Infrastructure (CDNL) had multiple buys totaling about $6.48M. Dyne (DYN), Butterfly Network (BFLY), Kinetik (KNTK), and PBF Energy (PBF) reported large sales.

Original reporting
Published Aug 18, 2026, 1:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 1:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$APLM
Bullish
medium confidence
Mentioned
$APLM · $CDNL · $DYN · $BFLY · $KNTK · $PBF
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$APLMBullishLow
01

Why it matters

For traders, the actionable signal is mainly sentiment and near-term positioning around recent weakness (buys) or profit-taking (sells). It does not introduce new earnings, guidance, contracts, or regulatory outcomes.

02

Market read

This is a sentiment/positioning read-through from insider activity, not a fundamental catalyst report.

03

What to watch

The article lacks follow-on details such as lockups, future financing plans, or whether the private placements change ownership/control, which limits conviction on price direction.

Relevance 4/10Novelty 4/10Timing: insider transactions disclosed for Monday, with trades dated Aug. 13-14, 2026

Background

The piece is a multi-company roundup of insider trading disclosed on Monday, citing specific Form 6-K/transaction details and 10b5-1 mechanics.

Company-level read

Ticker impact

$APLMBullishMedium confidence
Context

CEO Hung-Wen Chen and CFO Peter Lin bought APLM shares in private placements on Aug. 14, 2026, at $12-$15 and $15, respectively.

Expected impact

Mild positive bias for the next few sessions, with follow-through dependent on broader biotech tape.

Evidence & confidence

The article provides specific insider purchase dates, prices, and private-placement linkage, but no new operational or financial guidance.

$CDNLBullishMedium confidence
Context

CDNL saw multiple insider buys on Aug. 14, 2026, including CEO Jeremy Simmons Spivey and directors Anthony Wood and Richard Lee, while the stock fell ~35% over the prior week.

Expected impact

Potential short-term stabilization or bounce, especially if the market continues to reward insider activity.

Evidence & confidence

The text includes transaction sizes, price ranges, and the context of a steep weekly decline, but does not disclose new earnings, contracts, or guidance.

$DYNBearishLow confidence
Context

DYN director Jason Rhodes sold about $65.2M of stock via a 10b5-1 plan on Aug. 13-14, 2026, near the stock’s ~$27.30 52-week high.

Expected impact

Slight negative bias for near-term trading, particularly if selling continues or buyers fade.

Evidence & confidence

The article is detailed on the sale mechanics and timing, but 10b5-1 plans often reduce interpretability as a directional signal.

$BFLYBearishLow confidence
Context

BFLY director Larry Robbins reported sales totaling about $20.6M between Aug. 13-17, 2026, after the stock surged ~526% over the past year.

Expected impact

Near-term upside may be capped; downside risk increases if momentum traders step aside.

Evidence & confidence

The article provides sale totals and price ranges, but no new company-specific fundamentals or guidance changes.

$KNTKBearishLow confidence
Context

KNTK director and 10% owner ISQ Global Fund II GP LLC sold ~360,337 shares for about $18.96M on Aug. 13-17, 2026, near the ~$54.12 52-week high.

Expected impact

Mild negative drift possible over days to weeks if liquidity tightens or buyers pause.

Evidence & confidence

The transaction details are clear, but insider sales are not the same as a new business development.

$PBFBearishLow confidence
Context

PBF saw a 10% owner director sell 216,356 shares for about $15.63M on Aug. 13-14, 2026, and another director sell about $12.3M after option exercise.

Expected impact

Slight negative bias, with potential for choppy trading if the market had been expecting continued upside momentum.

Evidence & confidence

The article includes sale sizes and timing, but provides no new operational or regulatory catalyst.

Market effects

Biotech and infrastructure/energy names show divergent insider behavior, but the article does not provide sector-wide fundamentals.

Primarily US-listed equities; no cross-market macro linkage is provided.

Limited, as the disclosures are company-specific insider transactions without global policy or supply-chain shocks.

Counterpoint

Insider sales can be routine (10b5-1 plans, option exercises) and insider buys can reflect diversification or private-placement mechanics rather than a new fundamental outlook.

Key entities

  • Apollomics Inc.

    CEO and CFO purchased shares in private placements on Aug. 14, 2026.

  • Cardinal Infrastructure Group Inc.

    CEO and directors bought shares on Aug. 14, 2026 amid a sharp weekly decline.

  • Dyne Therapeutics, Inc.

    Director sold shares via a 10b5-1 plan on Aug. 13-14, 2026.

  • Butterfly Network, Inc.

    Director reported sales totaling about $20.6M between Aug. 13-17, 2026.

  • Kinetik Holdings Inc.

    10% owner director sold about $18.96M of shares between Aug. 13-17, 2026.

Related articles

$KNTKMed

Kinetik stock price target raised to $62 by RBC on growth outlook

RBC Capital raised its price target on Kinetik Holdings (NYSE:KNTK) to $62 from $58, maintaining an Outperform rating. The stock, near its 52-week high, has returned 70% over the past year. RBC expects Kinetik to benefit from growing volumes and margin improvements in 2027 and beyond, forecasting a 10% adjusted EBITDA CAGR through 2030. Kinetik reported mixed Q3 2026 results, missing earnings estimates but beating revenue forecasts.

$CDNLMedAI 8/10

Cardinal Infra (CDNL) Q3 2026 Earnings Call Transcript

Cardinal Infra (CDNL) reported Q3 2026 revenue of $202M, up 65%, but adjusted EBITDA fell to $9M from $21M YoY. The company withdrew full-year guidance due to project estimate revisions and operational challenges. The board authorized a $50M share repurchase program. CFO Mike Rowe will step down, and the company is focusing on improving execution and profitability.

$CDNLMed

What Cardinal Infrastructure Group (CDNL) Said on Its Q3 Earnings Call

Cardinal Infrastructure Group (CDNL) reported Q3 earnings, citing $13.2M in cost estimate revisions due to project issues and market conditions. The company withdrew its annual outlook but expects Q4 adjusted EBITDA improvement. Backlog rose 26% YoY to $815.5M. Revenue increased 92% to $596M, but adjusted EBITDA margin fell to 10.6%. The board authorized a $50M stock buyback. CDNL postponed an acquisition to focus on operations.

$CDNLHighAI 8/10

Why is Cardinal Infrastructure stock plummeting today?

Cardinal Infrastructure Group (CDNL) shares fell 36.8% in pre-market trading after reporting Q3 2026 earnings below expectations, with a loss of $0.21 per share versus an estimated $0.41 gain. Revenue grew 65.1% YoY to $201.9M but missed forecasts, while adjusted EBITDA margin dropped to 4.2% from 17.5%. The company withdrew full-year guidance, postponed an acquisition, and faces a securities law firm investigation. The broader market also declined.